nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone—CYP2B6—Thiotepa—urinary bladder cancer	0.06	0.105	CbGbCtD
Testosterone—SLC22A7—Fluorouracil—urinary bladder cancer	0.0527	0.0926	CbGbCtD
Testosterone—ABCB1—Mitomycin—urinary bladder cancer	0.0406	0.0713	CbGbCtD
Testosterone—CYP1B1—Doxorubicin—urinary bladder cancer	0.0332	0.0583	CbGbCtD
Testosterone—SLC22A7—Methotrexate—urinary bladder cancer	0.0291	0.0511	CbGbCtD
Testosterone—ABCG2—Fluorouracil—urinary bladder cancer	0.0277	0.0487	CbGbCtD
Testosterone—ABCG2—Carboplatin—urinary bladder cancer	0.0275	0.0484	CbGbCtD
Testosterone—ABCG2—Cisplatin—urinary bladder cancer	0.0235	0.0413	CbGbCtD
Testosterone—ABCG2—Etoposide—urinary bladder cancer	0.0231	0.0406	CbGbCtD
Testosterone—SLCO1A2—Methotrexate—urinary bladder cancer	0.0204	0.0358	CbGbCtD
Testosterone—ALB—Fluorouracil—urinary bladder cancer	0.0191	0.0335	CbGbCtD
Testosterone—CYP3A4—Thiotepa—urinary bladder cancer	0.0184	0.0324	CbGbCtD
Testosterone—SLC22A8—Methotrexate—urinary bladder cancer	0.0178	0.0312	CbGbCtD
Testosterone—CYP2B6—Cisplatin—urinary bladder cancer	0.0166	0.0291	CbGbCtD
Testosterone—ABCG2—Doxorubicin—urinary bladder cancer	0.0158	0.0277	CbGbCtD
Testosterone—ABCG2—Methotrexate—urinary bladder cancer	0.0153	0.0268	CbGbCtD
Testosterone—CYP2C8—Fluorouracil—urinary bladder cancer	0.0148	0.0259	CbGbCtD
Testosterone—CYP3A5—Etoposide—urinary bladder cancer	0.0128	0.0225	CbGbCtD
Testosterone—CYP2C8—Etoposide—urinary bladder cancer	0.0123	0.0216	CbGbCtD
Testosterone—ABCB1—Gemcitabine—urinary bladder cancer	0.0117	0.0205	CbGbCtD
Testosterone—CYP2B6—Doxorubicin—urinary bladder cancer	0.0111	0.0195	CbGbCtD
Testosterone—ALB—Methotrexate—urinary bladder cancer	0.0105	0.0185	CbGbCtD
Testosterone—CYP2C9—Fluorouracil—urinary bladder cancer	0.0103	0.0181	CbGbCtD
Testosterone—AR—scrotum—urinary bladder cancer	0.00977	0.118	CbGeAlD
Testosterone—CYP2C9—Cisplatin—urinary bladder cancer	0.00875	0.0154	CbGbCtD
Testosterone—ABCB1—Cisplatin—urinary bladder cancer	0.00849	0.0149	CbGbCtD
Testosterone—ABCB1—Etoposide—urinary bladder cancer	0.00834	0.0146	CbGbCtD
Testosterone—ABCB1—Doxorubicin—urinary bladder cancer	0.00569	0.00999	CbGbCtD
Testosterone—ABCB1—Methotrexate—urinary bladder cancer	0.00551	0.00968	CbGbCtD
Testosterone—CYP3A4—Etoposide—urinary bladder cancer	0.005	0.00877	CbGbCtD
Testosterone—AR—penis—urinary bladder cancer	0.00441	0.053	CbGeAlD
Testosterone—CYP3A4—Doxorubicin—urinary bladder cancer	0.00341	0.00598	CbGbCtD
Testosterone—SLC22A8—urine—urinary bladder cancer	0.00324	0.039	CbGeAlD
Testosterone—CYP2C19—urine—urinary bladder cancer	0.00272	0.0327	CbGeAlD
Testosterone—SLC10A1—prostate gland—urinary bladder cancer	0.00226	0.0272	CbGeAlD
Testosterone—CYP2C9—urine—urinary bladder cancer	0.00211	0.0254	CbGeAlD
Testosterone—SLC10A1—seminal vesicle—urinary bladder cancer	0.00191	0.023	CbGeAlD
Testosterone—CYP3A4—urine—urinary bladder cancer	0.00161	0.0193	CbGeAlD
Testosterone—SLC10A1—renal system—urinary bladder cancer	0.00154	0.0185	CbGeAlD
Testosterone—SHBG—prostate gland—urinary bladder cancer	0.00147	0.0177	CbGeAlD
Testosterone—SLC22A7—renal system—urinary bladder cancer	0.00137	0.0165	CbGeAlD
Testosterone—SLC22A4—prostate gland—urinary bladder cancer	0.00133	0.016	CbGeAlD
Testosterone—SLC10A1—female reproductive system—urinary bladder cancer	0.00123	0.0148	CbGeAlD
Testosterone—SLC22A3—prostate gland—urinary bladder cancer	0.00121	0.0146	CbGeAlD
Testosterone—CYP19A1—prostate gland—urinary bladder cancer	0.00119	0.0143	CbGeAlD
Testosterone—SLC22A8—prostate gland—urinary bladder cancer	0.00116	0.014	CbGeAlD
Testosterone—SLC22A4—seminal vesicle—urinary bladder cancer	0.00112	0.0135	CbGeAlD
Testosterone—CYP1B1—prostate gland—urinary bladder cancer	0.00111	0.0134	CbGeAlD
Testosterone—AR—prostate gland—urinary bladder cancer	0.00105	0.0127	CbGeAlD
Testosterone—SLC22A3—seminal vesicle—urinary bladder cancer	0.00102	0.0123	CbGeAlD
Testosterone—CYP11A1—female reproductive system—urinary bladder cancer	0.000999	0.012	CbGeAlD
Testosterone—MAOA—prostate gland—urinary bladder cancer	0.000955	0.0115	CbGeAlD
Testosterone—SLC22A4—renal system—urinary bladder cancer	0.000906	0.0109	CbGeAlD
Testosterone—AR—seminal vesicle—urinary bladder cancer	0.00089	0.0107	CbGeAlD
Testosterone—Trilostane—ESR2—urinary bladder cancer	0.000866	0.146	CrCbGaD
Testosterone—SLC22A1—renal system—urinary bladder cancer	0.000862	0.0104	CbGeAlD
Testosterone—SLC22A3—smooth muscle tissue—urinary bladder cancer	0.000856	0.0103	CbGeAlD
Testosterone—SLCO1A2—renal system—urinary bladder cancer	0.00083	0.00999	CbGeAlD
Testosterone—ABCG2—prostate gland—urinary bladder cancer	0.000828	0.00996	CbGeAlD
Testosterone—SLC22A3—renal system—urinary bladder cancer	0.000824	0.00992	CbGeAlD
Testosterone—SLC22A3—urethra—urinary bladder cancer	0.00081	0.00974	CbGeAlD
Testosterone—MAOA—seminal vesicle—urinary bladder cancer	0.000808	0.00972	CbGeAlD
Testosterone—SHBG—female reproductive system—urinary bladder cancer	0.000801	0.00964	CbGeAlD
Testosterone—SLC22A8—renal system—urinary bladder cancer	0.000793	0.00954	CbGeAlD
Testosterone—CYP1B1—smooth muscle tissue—urinary bladder cancer	0.000787	0.00947	CbGeAlD
Testosterone—AR—epithelium—urinary bladder cancer	0.000773	0.00931	CbGeAlD
Testosterone—CYP3A5—prostate gland—urinary bladder cancer	0.000768	0.00925	CbGeAlD
Testosterone—CYP1B1—renal system—urinary bladder cancer	0.000758	0.00912	CbGeAlD
Testosterone—AR—smooth muscle tissue—urinary bladder cancer	0.000745	0.00897	CbGeAlD
Testosterone—SLC22A4—female reproductive system—urinary bladder cancer	0.000725	0.00873	CbGeAlD
Testosterone—SHBG—vagina—urinary bladder cancer	0.000724	0.00871	CbGeAlD
Testosterone—AR—renal system—urinary bladder cancer	0.000717	0.00863	CbGeAlD
Testosterone—AR—urethra—urinary bladder cancer	0.000705	0.00848	CbGeAlD
Testosterone—Estramustine—ESR2—urinary bladder cancer	0.000702	0.119	CrCbGaD
Testosterone—ABCG2—seminal vesicle—urinary bladder cancer	0.0007	0.00843	CbGeAlD
Testosterone—SLC22A3—female reproductive system—urinary bladder cancer	0.00066	0.00794	CbGeAlD
Testosterone—SLC22A4—vagina—urinary bladder cancer	0.000656	0.0079	CbGeAlD
Testosterone—MAOA—renal system—urinary bladder cancer	0.000651	0.00783	CbGeAlD
Testosterone—CYP19A1—female reproductive system—urinary bladder cancer	0.000649	0.00781	CbGeAlD
Testosterone—MAOA—urethra—urinary bladder cancer	0.000639	0.00769	CbGeAlD
Testosterone—SLC22A1—vagina—urinary bladder cancer	0.000625	0.00752	CbGeAlD
Testosterone—CYP1B1—female reproductive system—urinary bladder cancer	0.000607	0.0073	CbGeAlD
Testosterone—SLC22A3—vagina—urinary bladder cancer	0.000597	0.00719	CbGeAlD
Testosterone—CYP11A1—lymph node—urinary bladder cancer	0.000584	0.00703	CbGeAlD
Testosterone—CYP2C8—renal system—urinary bladder cancer	0.00058	0.00698	CbGeAlD
Testosterone—CYP1A1—epithelium—urinary bladder cancer	0.000577	0.00695	CbGeAlD
Testosterone—AR—female reproductive system—urinary bladder cancer	0.000575	0.00692	CbGeAlD
Testosterone—ABCG2—urethra—urinary bladder cancer	0.000554	0.00667	CbGeAlD
Testosterone—CYP1A1—renal system—urinary bladder cancer	0.000536	0.00645	CbGeAlD
Testosterone—Trilostane—ESR1—urinary bladder cancer	0.000533	0.0902	CrCbGaD
Testosterone—CYP1A1—urethra—urinary bladder cancer	0.000526	0.00633	CbGeAlD
Testosterone—CYP3A5—renal system—urinary bladder cancer	0.000524	0.0063	CbGeAlD
Testosterone—MAOA—female reproductive system—urinary bladder cancer	0.000521	0.00627	CbGeAlD
Testosterone—CYP2B6—renal system—urinary bladder cancer	0.00052	0.00626	CbGeAlD
Testosterone—AR—vagina—urinary bladder cancer	0.00052	0.00625	CbGeAlD
Testosterone—Norgestimate—ESR1—urinary bladder cancer	0.000493	0.0834	CrCbGaD
Testosterone—CYP2C19—vagina—urinary bladder cancer	0.000481	0.00579	CbGeAlD
Testosterone—MAOA—vagina—urinary bladder cancer	0.000471	0.00567	CbGeAlD
Testosterone—CYP2C8—female reproductive system—urinary bladder cancer	0.000465	0.00559	CbGeAlD
Testosterone—Estramustine—ESR1—urinary bladder cancer	0.000433	0.0732	CrCbGaD
Testosterone—CYP1A1—female reproductive system—urinary bladder cancer	0.000429	0.00516	CbGeAlD
Testosterone—Etonogestrel—ESR1—urinary bladder cancer	0.000426	0.0721	CrCbGaD
Testosterone—SLC22A4—lymph node—urinary bladder cancer	0.000424	0.00511	CbGeAlD
Testosterone—CYP2C8—vagina—urinary bladder cancer	0.00042	0.00506	CbGeAlD
Testosterone—CYP2B6—female reproductive system—urinary bladder cancer	0.000417	0.00502	CbGeAlD
Testosterone—CYP2C9—female reproductive system—urinary bladder cancer	0.000413	0.00497	CbGeAlD
Testosterone—ABCG2—vagina—urinary bladder cancer	0.000409	0.00492	CbGeAlD
Testosterone—ABCB1—prostate gland—urinary bladder cancer	0.000408	0.00491	CbGeAlD
Testosterone—CYP3A4—renal system—urinary bladder cancer	0.000393	0.00473	CbGeAlD
Testosterone—CYP1A1—vagina—urinary bladder cancer	0.000388	0.00467	CbGeAlD
Testosterone—ALB—lymph node—urinary bladder cancer	0.000387	0.00466	CbGeAlD
Testosterone—SLC22A3—lymph node—urinary bladder cancer	0.000386	0.00465	CbGeAlD
Testosterone—CYP19A1—lymph node—urinary bladder cancer	0.00038	0.00457	CbGeAlD
Testosterone—CYP3A5—vagina—urinary bladder cancer	0.000379	0.00457	CbGeAlD
Testosterone—CYP2B6—vagina—urinary bladder cancer	0.000377	0.00454	CbGeAlD
Testosterone—Estrone—ESR2—urinary bladder cancer	0.000359	0.0608	CrCbGaD
Testosterone—CYP1B1—lymph node—urinary bladder cancer	0.000355	0.00427	CbGeAlD
Testosterone—ABCB1—seminal vesicle—urinary bladder cancer	0.000345	0.00415	CbGeAlD
Testosterone—AR—lymph node—urinary bladder cancer	0.000336	0.00405	CbGeAlD
Testosterone—CYP3A4—female reproductive system—urinary bladder cancer	0.000315	0.00379	CbGeAlD
Testosterone—MAOA—lymph node—urinary bladder cancer	0.000305	0.00367	CbGeAlD
Testosterone—Levonorgestrel—ESR1—urinary bladder cancer	0.000302	0.051	CrCbGaD
Testosterone—ABCB1—epithelium—urinary bladder cancer	0.0003	0.00361	CbGeAlD
Testosterone—Fluoxymesterone—ESR1—urinary bladder cancer	0.000287	0.0486	CrCbGaD
Testosterone—ABCB1—renal system—urinary bladder cancer	0.000278	0.00335	CbGeAlD
Testosterone—Danazol—ESR1—urinary bladder cancer	0.000275	0.0465	CrCbGaD
Testosterone—ABCB1—urethra—urinary bladder cancer	0.000273	0.00329	CbGeAlD
Testosterone—Estradiol—ESR2—urinary bladder cancer	0.000272	0.0461	CrCbGaD
Testosterone—ABCG2—lymph node—urinary bladder cancer	0.000264	0.00318	CbGeAlD
Testosterone—CYP1A1—lymph node—urinary bladder cancer	0.000251	0.00302	CbGeAlD
Testosterone—Medroxyprogesterone Acetate—ESR1—urinary bladder cancer	0.000247	0.0417	CrCbGaD
Testosterone—ABCB1—female reproductive system—urinary bladder cancer	0.000223	0.00268	CbGeAlD
Testosterone—Estrone—ESR1—urinary bladder cancer	0.000221	0.0375	CrCbGaD
Testosterone—ABCB1—vagina—urinary bladder cancer	0.000201	0.00243	CbGeAlD
Testosterone—Drospirenone—PTGS2—urinary bladder cancer	0.000185	0.0312	CrCbGaD
Testosterone—Estradiol—ESR1—urinary bladder cancer	0.000168	0.0284	CrCbGaD
Testosterone—Progesterone—ESR1—urinary bladder cancer	0.000142	0.0241	CrCbGaD
Testosterone—ABCB1—lymph node—urinary bladder cancer	0.00013	0.00157	CbGeAlD
Testosterone—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	9.41e-05	0.000488	CcSEcCtD
Testosterone—Haemoglobin—Methotrexate—urinary bladder cancer	9.41e-05	0.000488	CcSEcCtD
Testosterone—Haemorrhage—Methotrexate—urinary bladder cancer	9.36e-05	0.000485	CcSEcCtD
Testosterone—Sweating—Epirubicin—urinary bladder cancer	9.35e-05	0.000485	CcSEcCtD
Testosterone—Pollakiuria—Doxorubicin—urinary bladder cancer	9.35e-05	0.000485	CcSEcCtD
Testosterone—Asthenia—Gemcitabine—urinary bladder cancer	9.33e-05	0.000484	CcSEcCtD
Testosterone—Haematuria—Epirubicin—urinary bladder cancer	9.3e-05	0.000483	CcSEcCtD
Testosterone—Urinary tract disorder—Methotrexate—urinary bladder cancer	9.24e-05	0.000479	CcSEcCtD
Testosterone—Hepatobiliary disease—Epirubicin—urinary bladder cancer	9.23e-05	0.000479	CcSEcCtD
Testosterone—Weight increased—Doxorubicin—urinary bladder cancer	9.21e-05	0.000478	CcSEcCtD
Testosterone—Pruritus—Gemcitabine—urinary bladder cancer	9.2e-05	0.000477	CcSEcCtD
Testosterone—Nausea—Thiotepa—urinary bladder cancer	9.18e-05	0.000476	CcSEcCtD
Testosterone—Urethral disorder—Methotrexate—urinary bladder cancer	9.17e-05	0.000476	CcSEcCtD
Testosterone—Sinusitis—Epirubicin—urinary bladder cancer	9.15e-05	0.000475	CcSEcCtD
Testosterone—Feeling abnormal—Etoposide—urinary bladder cancer	9.15e-05	0.000474	CcSEcCtD
Testosterone—Pneumonia—Doxorubicin—urinary bladder cancer	9.08e-05	0.000471	CcSEcCtD
Testosterone—Gastrointestinal pain—Etoposide—urinary bladder cancer	9.08e-05	0.000471	CcSEcCtD
Testosterone—Pruritus—Fluorouracil—urinary bladder cancer	9.04e-05	0.000469	CcSEcCtD
Testosterone—Infestation—Doxorubicin—urinary bladder cancer	9.03e-05	0.000468	CcSEcCtD
Testosterone—Infestation NOS—Doxorubicin—urinary bladder cancer	9.03e-05	0.000468	CcSEcCtD
Testosterone—Hypersensitivity—Cisplatin—urinary bladder cancer	8.93e-05	0.000463	CcSEcCtD
Testosterone—Diarrhoea—Gemcitabine—urinary bladder cancer	8.89e-05	0.000461	CcSEcCtD
Testosterone—Renal failure—Doxorubicin—urinary bladder cancer	8.87e-05	0.00046	CcSEcCtD
Testosterone—Urticaria—Etoposide—urinary bladder cancer	8.82e-05	0.000457	CcSEcCtD
Testosterone—Haemoglobin—Epirubicin—urinary bladder cancer	8.8e-05	0.000457	CcSEcCtD
Testosterone—Stomatitis—Doxorubicin—urinary bladder cancer	8.8e-05	0.000456	CcSEcCtD
Testosterone—Rhinitis—Epirubicin—urinary bladder cancer	8.78e-05	0.000455	CcSEcCtD
Testosterone—Abdominal pain—Etoposide—urinary bladder cancer	8.77e-05	0.000455	CcSEcCtD
Testosterone—Urinary tract infection—Doxorubicin—urinary bladder cancer	8.77e-05	0.000455	CcSEcCtD
Testosterone—Haemorrhage—Epirubicin—urinary bladder cancer	8.76e-05	0.000454	CcSEcCtD
Testosterone—Eye disorder—Methotrexate—urinary bladder cancer	8.75e-05	0.000454	CcSEcCtD
Testosterone—Diarrhoea—Fluorouracil—urinary bladder cancer	8.74e-05	0.000454	CcSEcCtD
Testosterone—Tinnitus—Methotrexate—urinary bladder cancer	8.73e-05	0.000453	CcSEcCtD
Testosterone—Asthenia—Cisplatin—urinary bladder cancer	8.69e-05	0.000451	CcSEcCtD
Testosterone—Cardiac disorder—Methotrexate—urinary bladder cancer	8.69e-05	0.000451	CcSEcCtD
Testosterone—Sweating—Doxorubicin—urinary bladder cancer	8.65e-05	0.000449	CcSEcCtD
Testosterone—Urinary tract disorder—Epirubicin—urinary bladder cancer	8.65e-05	0.000449	CcSEcCtD
Testosterone—Oedema peripheral—Epirubicin—urinary bladder cancer	8.63e-05	0.000448	CcSEcCtD
Testosterone—Haematuria—Doxorubicin—urinary bladder cancer	8.61e-05	0.000446	CcSEcCtD
Testosterone—Connective tissue disorder—Epirubicin—urinary bladder cancer	8.61e-05	0.000446	CcSEcCtD
Testosterone—Urethral disorder—Epirubicin—urinary bladder cancer	8.58e-05	0.000445	CcSEcCtD
Testosterone—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	8.54e-05	0.000443	CcSEcCtD
Testosterone—Angiopathy—Methotrexate—urinary bladder cancer	8.49e-05	0.00044	CcSEcCtD
Testosterone—Sinusitis—Doxorubicin—urinary bladder cancer	8.47e-05	0.000439	CcSEcCtD
Testosterone—Immune system disorder—Methotrexate—urinary bladder cancer	8.45e-05	0.000438	CcSEcCtD
Testosterone—Dizziness—Fluorouracil—urinary bladder cancer	8.45e-05	0.000438	CcSEcCtD
Testosterone—Mediastinal disorder—Methotrexate—urinary bladder cancer	8.43e-05	0.000438	CcSEcCtD
Testosterone—Chills—Methotrexate—urinary bladder cancer	8.4e-05	0.000436	CcSEcCtD
Testosterone—Diarrhoea—Cisplatin—urinary bladder cancer	8.29e-05	0.00043	CcSEcCtD
Testosterone—Alopecia—Methotrexate—urinary bladder cancer	8.27e-05	0.000429	CcSEcCtD
Testosterone—Vomiting—Gemcitabine—urinary bladder cancer	8.26e-05	0.000429	CcSEcCtD
Testosterone—Mental disorder—Methotrexate—urinary bladder cancer	8.2e-05	0.000425	CcSEcCtD
Testosterone—Rash—Gemcitabine—urinary bladder cancer	8.2e-05	0.000425	CcSEcCtD
Testosterone—Dermatitis—Gemcitabine—urinary bladder cancer	8.19e-05	0.000425	CcSEcCtD
Testosterone—Eye disorder—Epirubicin—urinary bladder cancer	8.18e-05	0.000425	CcSEcCtD
Testosterone—Hypersensitivity—Etoposide—urinary bladder cancer	8.18e-05	0.000424	CcSEcCtD
Testosterone—Tinnitus—Epirubicin—urinary bladder cancer	8.17e-05	0.000424	CcSEcCtD
Testosterone—Malnutrition—Methotrexate—urinary bladder cancer	8.15e-05	0.000423	CcSEcCtD
Testosterone—Erythema—Methotrexate—urinary bladder cancer	8.15e-05	0.000423	CcSEcCtD
Testosterone—Haemoglobin—Doxorubicin—urinary bladder cancer	8.14e-05	0.000422	CcSEcCtD
Testosterone—Headache—Gemcitabine—urinary bladder cancer	8.14e-05	0.000422	CcSEcCtD
Testosterone—Cardiac disorder—Epirubicin—urinary bladder cancer	8.13e-05	0.000422	CcSEcCtD
Testosterone—Vomiting—Fluorouracil—urinary bladder cancer	8.13e-05	0.000422	CcSEcCtD
Testosterone—Rhinitis—Doxorubicin—urinary bladder cancer	8.12e-05	0.000421	CcSEcCtD
Testosterone—Haemorrhage—Doxorubicin—urinary bladder cancer	8.1e-05	0.00042	CcSEcCtD
Testosterone—Rash—Fluorouracil—urinary bladder cancer	8.06e-05	0.000418	CcSEcCtD
Testosterone—Dermatitis—Fluorouracil—urinary bladder cancer	8.05e-05	0.000418	CcSEcCtD
Testosterone—Headache—Fluorouracil—urinary bladder cancer	8.01e-05	0.000415	CcSEcCtD
Testosterone—Urinary tract disorder—Doxorubicin—urinary bladder cancer	8e-05	0.000415	CcSEcCtD
Testosterone—Oedema peripheral—Doxorubicin—urinary bladder cancer	7.98e-05	0.000414	CcSEcCtD
Testosterone—Dysgeusia—Methotrexate—urinary bladder cancer	7.98e-05	0.000414	CcSEcCtD
Testosterone—Asthenia—Etoposide—urinary bladder cancer	7.96e-05	0.000413	CcSEcCtD
Testosterone—Connective tissue disorder—Doxorubicin—urinary bladder cancer	7.96e-05	0.000413	CcSEcCtD
Testosterone—Angiopathy—Epirubicin—urinary bladder cancer	7.95e-05	0.000412	CcSEcCtD
Testosterone—Urethral disorder—Doxorubicin—urinary bladder cancer	7.94e-05	0.000412	CcSEcCtD
Testosterone—Immune system disorder—Epirubicin—urinary bladder cancer	7.91e-05	0.00041	CcSEcCtD
Testosterone—Mediastinal disorder—Epirubicin—urinary bladder cancer	7.89e-05	0.000409	CcSEcCtD
Testosterone—Back pain—Methotrexate—urinary bladder cancer	7.88e-05	0.000409	CcSEcCtD
Testosterone—Chills—Epirubicin—urinary bladder cancer	7.86e-05	0.000408	CcSEcCtD
Testosterone—Pruritus—Etoposide—urinary bladder cancer	7.85e-05	0.000407	CcSEcCtD
Testosterone—Alopecia—Epirubicin—urinary bladder cancer	7.74e-05	0.000401	CcSEcCtD
Testosterone—Nausea—Gemcitabine—urinary bladder cancer	7.72e-05	0.000401	CcSEcCtD
Testosterone—Vomiting—Cisplatin—urinary bladder cancer	7.7e-05	0.0004	CcSEcCtD
Testosterone—Mental disorder—Epirubicin—urinary bladder cancer	7.67e-05	0.000398	CcSEcCtD
Testosterone—Rash—Cisplatin—urinary bladder cancer	7.64e-05	0.000396	CcSEcCtD
Testosterone—Dermatitis—Cisplatin—urinary bladder cancer	7.63e-05	0.000396	CcSEcCtD
Testosterone—Erythema—Epirubicin—urinary bladder cancer	7.62e-05	0.000395	CcSEcCtD
Testosterone—Malnutrition—Epirubicin—urinary bladder cancer	7.62e-05	0.000395	CcSEcCtD
Testosterone—Diarrhoea—Etoposide—urinary bladder cancer	7.59e-05	0.000394	CcSEcCtD
Testosterone—Nausea—Fluorouracil—urinary bladder cancer	7.59e-05	0.000394	CcSEcCtD
Testosterone—Eye disorder—Doxorubicin—urinary bladder cancer	7.57e-05	0.000393	CcSEcCtD
Testosterone—Ill-defined disorder—Methotrexate—urinary bladder cancer	7.56e-05	0.000392	CcSEcCtD
Testosterone—Tinnitus—Doxorubicin—urinary bladder cancer	7.56e-05	0.000392	CcSEcCtD
Testosterone—Anaemia—Methotrexate—urinary bladder cancer	7.53e-05	0.000391	CcSEcCtD
Testosterone—Cardiac disorder—Doxorubicin—urinary bladder cancer	7.52e-05	0.00039	CcSEcCtD
Testosterone—Tension—Epirubicin—urinary bladder cancer	7.48e-05	0.000388	CcSEcCtD
Testosterone—Dysgeusia—Epirubicin—urinary bladder cancer	7.47e-05	0.000387	CcSEcCtD
Testosterone—Nervousness—Epirubicin—urinary bladder cancer	7.4e-05	0.000384	CcSEcCtD
Testosterone—Back pain—Epirubicin—urinary bladder cancer	7.37e-05	0.000383	CcSEcCtD
Testosterone—Angiopathy—Doxorubicin—urinary bladder cancer	7.35e-05	0.000381	CcSEcCtD
Testosterone—Malaise—Methotrexate—urinary bladder cancer	7.35e-05	0.000381	CcSEcCtD
Testosterone—Dizziness—Etoposide—urinary bladder cancer	7.34e-05	0.000381	CcSEcCtD
Testosterone—Immune system disorder—Doxorubicin—urinary bladder cancer	7.32e-05	0.00038	CcSEcCtD
Testosterone—Vertigo—Methotrexate—urinary bladder cancer	7.32e-05	0.00038	CcSEcCtD
Testosterone—Mediastinal disorder—Doxorubicin—urinary bladder cancer	7.3e-05	0.000379	CcSEcCtD
Testosterone—Chills—Doxorubicin—urinary bladder cancer	7.27e-05	0.000377	CcSEcCtD
Testosterone—Nausea—Cisplatin—urinary bladder cancer	7.2e-05	0.000373	CcSEcCtD
Testosterone—Alopecia—Doxorubicin—urinary bladder cancer	7.16e-05	0.000371	CcSEcCtD
Testosterone—Cough—Methotrexate—urinary bladder cancer	7.11e-05	0.000369	CcSEcCtD
Testosterone—Mental disorder—Doxorubicin—urinary bladder cancer	7.1e-05	0.000368	CcSEcCtD
Testosterone—Ill-defined disorder—Epirubicin—urinary bladder cancer	7.07e-05	0.000367	CcSEcCtD
Testosterone—Vomiting—Etoposide—urinary bladder cancer	7.06e-05	0.000366	CcSEcCtD
Testosterone—Malnutrition—Doxorubicin—urinary bladder cancer	7.05e-05	0.000366	CcSEcCtD
Testosterone—Erythema—Doxorubicin—urinary bladder cancer	7.05e-05	0.000366	CcSEcCtD
Testosterone—Anaemia—Epirubicin—urinary bladder cancer	7.05e-05	0.000366	CcSEcCtD
Testosterone—Agitation—Epirubicin—urinary bladder cancer	7.01e-05	0.000363	CcSEcCtD
Testosterone—Rash—Etoposide—urinary bladder cancer	7e-05	0.000363	CcSEcCtD
Testosterone—Dermatitis—Etoposide—urinary bladder cancer	6.99e-05	0.000363	CcSEcCtD
Testosterone—Headache—Etoposide—urinary bladder cancer	6.95e-05	0.000361	CcSEcCtD
Testosterone—Chest pain—Methotrexate—urinary bladder cancer	6.94e-05	0.00036	CcSEcCtD
Testosterone—Arthralgia—Methotrexate—urinary bladder cancer	6.94e-05	0.00036	CcSEcCtD
Testosterone—Myalgia—Methotrexate—urinary bladder cancer	6.94e-05	0.00036	CcSEcCtD
Testosterone—Tension—Doxorubicin—urinary bladder cancer	6.92e-05	0.000359	CcSEcCtD
Testosterone—Dysgeusia—Doxorubicin—urinary bladder cancer	6.91e-05	0.000358	CcSEcCtD
Testosterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	6.89e-05	0.000357	CcSEcCtD
Testosterone—Malaise—Epirubicin—urinary bladder cancer	6.88e-05	0.000357	CcSEcCtD
Testosterone—Discomfort—Methotrexate—urinary bladder cancer	6.85e-05	0.000355	CcSEcCtD
Testosterone—Nervousness—Doxorubicin—urinary bladder cancer	6.85e-05	0.000355	CcSEcCtD
Testosterone—Vertigo—Epirubicin—urinary bladder cancer	6.85e-05	0.000355	CcSEcCtD
Testosterone—Syncope—Epirubicin—urinary bladder cancer	6.84e-05	0.000355	CcSEcCtD
Testosterone—Back pain—Doxorubicin—urinary bladder cancer	6.82e-05	0.000354	CcSEcCtD
Testosterone—Palpitations—Epirubicin—urinary bladder cancer	6.74e-05	0.000349	CcSEcCtD
Testosterone—Confusional state—Methotrexate—urinary bladder cancer	6.7e-05	0.000348	CcSEcCtD
Testosterone—Loss of consciousness—Epirubicin—urinary bladder cancer	6.7e-05	0.000348	CcSEcCtD
Testosterone—Cough—Epirubicin—urinary bladder cancer	6.65e-05	0.000345	CcSEcCtD
Testosterone—Anaphylactic shock—Methotrexate—urinary bladder cancer	6.65e-05	0.000345	CcSEcCtD
Testosterone—Infection—Methotrexate—urinary bladder cancer	6.61e-05	0.000343	CcSEcCtD
Testosterone—Nausea—Etoposide—urinary bladder cancer	6.59e-05	0.000342	CcSEcCtD
Testosterone—Hypertension—Epirubicin—urinary bladder cancer	6.58e-05	0.000341	CcSEcCtD
Testosterone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	6.55e-05	0.00034	CcSEcCtD
Testosterone—Nervous system disorder—Methotrexate—urinary bladder cancer	6.52e-05	0.000338	CcSEcCtD
Testosterone—Anaemia—Doxorubicin—urinary bladder cancer	6.52e-05	0.000338	CcSEcCtD
Testosterone—Thrombocytopenia—Methotrexate—urinary bladder cancer	6.51e-05	0.000338	CcSEcCtD
Testosterone—Arthralgia—Epirubicin—urinary bladder cancer	6.49e-05	0.000337	CcSEcCtD
Testosterone—Chest pain—Epirubicin—urinary bladder cancer	6.49e-05	0.000337	CcSEcCtD
Testosterone—Myalgia—Epirubicin—urinary bladder cancer	6.49e-05	0.000337	CcSEcCtD
Testosterone—Agitation—Doxorubicin—urinary bladder cancer	6.48e-05	0.000336	CcSEcCtD
Testosterone—Anxiety—Epirubicin—urinary bladder cancer	6.47e-05	0.000336	CcSEcCtD
Testosterone—Skin disorder—Methotrexate—urinary bladder cancer	6.46e-05	0.000335	CcSEcCtD
Testosterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	6.45e-05	0.000334	CcSEcCtD
Testosterone—Hyperhidrosis—Methotrexate—urinary bladder cancer	6.43e-05	0.000333	CcSEcCtD
Testosterone—Discomfort—Epirubicin—urinary bladder cancer	6.41e-05	0.000333	CcSEcCtD
Testosterone—Malaise—Doxorubicin—urinary bladder cancer	6.36e-05	0.00033	CcSEcCtD
Testosterone—Dry mouth—Epirubicin—urinary bladder cancer	6.35e-05	0.000329	CcSEcCtD
Testosterone—Vertigo—Doxorubicin—urinary bladder cancer	6.34e-05	0.000329	CcSEcCtD
Testosterone—Syncope—Doxorubicin—urinary bladder cancer	6.33e-05	0.000328	CcSEcCtD
Testosterone—Confusional state—Epirubicin—urinary bladder cancer	6.27e-05	0.000325	CcSEcCtD
Testosterone—Palpitations—Doxorubicin—urinary bladder cancer	6.23e-05	0.000323	CcSEcCtD
Testosterone—Anaphylactic shock—Epirubicin—urinary bladder cancer	6.22e-05	0.000323	CcSEcCtD
Testosterone—Oedema—Epirubicin—urinary bladder cancer	6.22e-05	0.000323	CcSEcCtD
Testosterone—Loss of consciousness—Doxorubicin—urinary bladder cancer	6.2e-05	0.000322	CcSEcCtD
Testosterone—Infection—Epirubicin—urinary bladder cancer	6.18e-05	0.000321	CcSEcCtD
Testosterone—Cough—Doxorubicin—urinary bladder cancer	6.16e-05	0.000319	CcSEcCtD
Testosterone—Shock—Epirubicin—urinary bladder cancer	6.12e-05	0.000318	CcSEcCtD
Testosterone—Nervous system disorder—Epirubicin—urinary bladder cancer	6.1e-05	0.000317	CcSEcCtD
Testosterone—Thrombocytopenia—Epirubicin—urinary bladder cancer	6.09e-05	0.000316	CcSEcCtD
Testosterone—Hypertension—Doxorubicin—urinary bladder cancer	6.09e-05	0.000316	CcSEcCtD
Testosterone—Tachycardia—Epirubicin—urinary bladder cancer	6.07e-05	0.000315	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	6.06e-05	0.000314	CcSEcCtD
Testosterone—Skin disorder—Epirubicin—urinary bladder cancer	6.04e-05	0.000314	CcSEcCtD
Testosterone—Hyperhidrosis—Epirubicin—urinary bladder cancer	6.02e-05	0.000312	CcSEcCtD
Testosterone—Insomnia—Methotrexate—urinary bladder cancer	6.01e-05	0.000312	CcSEcCtD
Testosterone—Myalgia—Doxorubicin—urinary bladder cancer	6.01e-05	0.000312	CcSEcCtD
Testosterone—Chest pain—Doxorubicin—urinary bladder cancer	6.01e-05	0.000312	CcSEcCtD
Testosterone—Arthralgia—Doxorubicin—urinary bladder cancer	6.01e-05	0.000312	CcSEcCtD
Testosterone—Anxiety—Doxorubicin—urinary bladder cancer	5.98e-05	0.00031	CcSEcCtD
Testosterone—Paraesthesia—Methotrexate—urinary bladder cancer	5.97e-05	0.00031	CcSEcCtD
Testosterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	5.96e-05	0.000309	CcSEcCtD
Testosterone—Discomfort—Doxorubicin—urinary bladder cancer	5.93e-05	0.000308	CcSEcCtD
Testosterone—Dyspnoea—Methotrexate—urinary bladder cancer	5.93e-05	0.000307	CcSEcCtD
Testosterone—Dry mouth—Doxorubicin—urinary bladder cancer	5.87e-05	0.000305	CcSEcCtD
Testosterone—Confusional state—Doxorubicin—urinary bladder cancer	5.8e-05	0.000301	CcSEcCtD
Testosterone—Oedema—Doxorubicin—urinary bladder cancer	5.76e-05	0.000299	CcSEcCtD
Testosterone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	5.76e-05	0.000299	CcSEcCtD
Testosterone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	5.74e-05	0.000298	CcSEcCtD
Testosterone—Fatigue—Methotrexate—urinary bladder cancer	5.73e-05	0.000297	CcSEcCtD
Testosterone—Infection—Doxorubicin—urinary bladder cancer	5.72e-05	0.000297	CcSEcCtD
Testosterone—Pain—Methotrexate—urinary bladder cancer	5.69e-05	0.000295	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	5.67e-05	0.000294	CcSEcCtD
Testosterone—Shock—Doxorubicin—urinary bladder cancer	5.66e-05	0.000294	CcSEcCtD
Testosterone—Nervous system disorder—Doxorubicin—urinary bladder cancer	5.65e-05	0.000293	CcSEcCtD
Testosterone—Thrombocytopenia—Doxorubicin—urinary bladder cancer	5.64e-05	0.000292	CcSEcCtD
Testosterone—Insomnia—Epirubicin—urinary bladder cancer	5.63e-05	0.000292	CcSEcCtD
Testosterone—Tachycardia—Doxorubicin—urinary bladder cancer	5.62e-05	0.000291	CcSEcCtD
Testosterone—Skin disorder—Doxorubicin—urinary bladder cancer	5.59e-05	0.00029	CcSEcCtD
Testosterone—Paraesthesia—Epirubicin—urinary bladder cancer	5.59e-05	0.00029	CcSEcCtD
Testosterone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	5.57e-05	0.000289	CcSEcCtD
Testosterone—Dyspnoea—Epirubicin—urinary bladder cancer	5.55e-05	0.000288	CcSEcCtD
Testosterone—Feeling abnormal—Methotrexate—urinary bladder cancer	5.48e-05	0.000284	CcSEcCtD
Testosterone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	5.44e-05	0.000282	CcSEcCtD
Testosterone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	5.37e-05	0.000279	CcSEcCtD
Testosterone—Fatigue—Epirubicin—urinary bladder cancer	5.36e-05	0.000278	CcSEcCtD
Testosterone—Pain—Epirubicin—urinary bladder cancer	5.32e-05	0.000276	CcSEcCtD
Testosterone—Urticaria—Methotrexate—urinary bladder cancer	5.28e-05	0.000274	CcSEcCtD
Testosterone—Abdominal pain—Methotrexate—urinary bladder cancer	5.26e-05	0.000273	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	5.25e-05	0.000272	CcSEcCtD
Testosterone—Insomnia—Doxorubicin—urinary bladder cancer	5.21e-05	0.00027	CcSEcCtD
Testosterone—Paraesthesia—Doxorubicin—urinary bladder cancer	5.17e-05	0.000268	CcSEcCtD
Testosterone—Dyspnoea—Doxorubicin—urinary bladder cancer	5.13e-05	0.000266	CcSEcCtD
Testosterone—Feeling abnormal—Epirubicin—urinary bladder cancer	5.13e-05	0.000266	CcSEcCtD
Testosterone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	5.09e-05	0.000264	CcSEcCtD
Testosterone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	4.97e-05	0.000258	CcSEcCtD
Testosterone—Fatigue—Doxorubicin—urinary bladder cancer	4.96e-05	0.000257	CcSEcCtD
Testosterone—Urticaria—Epirubicin—urinary bladder cancer	4.94e-05	0.000256	CcSEcCtD
Testosterone—Pain—Doxorubicin—urinary bladder cancer	4.92e-05	0.000255	CcSEcCtD
Testosterone—Abdominal pain—Epirubicin—urinary bladder cancer	4.92e-05	0.000255	CcSEcCtD
Testosterone—Hypersensitivity—Methotrexate—urinary bladder cancer	4.9e-05	0.000254	CcSEcCtD
Testosterone—Asthenia—Methotrexate—urinary bladder cancer	4.77e-05	0.000247	CcSEcCtD
Testosterone—Feeling abnormal—Doxorubicin—urinary bladder cancer	4.74e-05	0.000246	CcSEcCtD
Testosterone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	4.71e-05	0.000244	CcSEcCtD
Testosterone—Pruritus—Methotrexate—urinary bladder cancer	4.7e-05	0.000244	CcSEcCtD
Testosterone—Hypersensitivity—Epirubicin—urinary bladder cancer	4.58e-05	0.000238	CcSEcCtD
Testosterone—Urticaria—Doxorubicin—urinary bladder cancer	4.57e-05	0.000237	CcSEcCtD
Testosterone—Abdominal pain—Doxorubicin—urinary bladder cancer	4.55e-05	0.000236	CcSEcCtD
Testosterone—Diarrhoea—Methotrexate—urinary bladder cancer	4.55e-05	0.000236	CcSEcCtD
Testosterone—Asthenia—Epirubicin—urinary bladder cancer	4.46e-05	0.000232	CcSEcCtD
Testosterone—Pruritus—Epirubicin—urinary bladder cancer	4.4e-05	0.000228	CcSEcCtD
Testosterone—Dizziness—Methotrexate—urinary bladder cancer	4.4e-05	0.000228	CcSEcCtD
Testosterone—Diarrhoea—Epirubicin—urinary bladder cancer	4.26e-05	0.000221	CcSEcCtD
Testosterone—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.24e-05	0.00022	CcSEcCtD
Testosterone—Vomiting—Methotrexate—urinary bladder cancer	4.23e-05	0.000219	CcSEcCtD
Testosterone—Rash—Methotrexate—urinary bladder cancer	4.19e-05	0.000217	CcSEcCtD
Testosterone—Dermatitis—Methotrexate—urinary bladder cancer	4.19e-05	0.000217	CcSEcCtD
Testosterone—Headache—Methotrexate—urinary bladder cancer	4.17e-05	0.000216	CcSEcCtD
Testosterone—Asthenia—Doxorubicin—urinary bladder cancer	4.13e-05	0.000214	CcSEcCtD
Testosterone—Dizziness—Epirubicin—urinary bladder cancer	4.11e-05	0.000213	CcSEcCtD
Testosterone—Pruritus—Doxorubicin—urinary bladder cancer	4.07e-05	0.000211	CcSEcCtD
Testosterone—Vomiting—Epirubicin—urinary bladder cancer	3.96e-05	0.000205	CcSEcCtD
Testosterone—Nausea—Methotrexate—urinary bladder cancer	3.95e-05	0.000205	CcSEcCtD
Testosterone—Diarrhoea—Doxorubicin—urinary bladder cancer	3.94e-05	0.000204	CcSEcCtD
Testosterone—Rash—Epirubicin—urinary bladder cancer	3.92e-05	0.000204	CcSEcCtD
Testosterone—Dermatitis—Epirubicin—urinary bladder cancer	3.92e-05	0.000203	CcSEcCtD
Testosterone—Headache—Epirubicin—urinary bladder cancer	3.9e-05	0.000202	CcSEcCtD
Testosterone—Dizziness—Doxorubicin—urinary bladder cancer	3.81e-05	0.000197	CcSEcCtD
Testosterone—Nausea—Epirubicin—urinary bladder cancer	3.7e-05	0.000192	CcSEcCtD
Testosterone—Vomiting—Doxorubicin—urinary bladder cancer	3.66e-05	0.00019	CcSEcCtD
Testosterone—Rash—Doxorubicin—urinary bladder cancer	3.63e-05	0.000188	CcSEcCtD
Testosterone—Dermatitis—Doxorubicin—urinary bladder cancer	3.63e-05	0.000188	CcSEcCtD
Testosterone—Headache—Doxorubicin—urinary bladder cancer	3.61e-05	0.000187	CcSEcCtD
Testosterone—Nausea—Doxorubicin—urinary bladder cancer	3.42e-05	0.000177	CcSEcCtD
Testosterone—ALB—Metabolism—RRM2—urinary bladder cancer	1.08e-05	7.26e-05	CbGpPWpGaD
Testosterone—CYP19A1—Metabolism—ERCC2—urinary bladder cancer	1.07e-05	7.22e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	1.06e-05	7.15e-05	CbGpPWpGaD
Testosterone—CYP1B1—Metabolism—GPX1—urinary bladder cancer	1.05e-05	7.08e-05	CbGpPWpGaD
Testosterone—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.05e-05	7.05e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.05e-05	7.04e-05	CbGpPWpGaD
Testosterone—ALB—Hemostasis—IGF1—urinary bladder cancer	1.04e-05	6.96e-05	CbGpPWpGaD
Testosterone—MAOA—Metabolism—MTHFR—urinary bladder cancer	1.04e-05	6.96e-05	CbGpPWpGaD
Testosterone—CYP1B1—Metabolism—ERCC2—urinary bladder cancer	1.03e-05	6.96e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.02e-05	6.88e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.01e-05	6.82e-05	CbGpPWpGaD
Testosterone—ABCG2—Metabolism—TYMS—urinary bladder cancer	1.01e-05	6.81e-05	CbGpPWpGaD
Testosterone—CYP19A1—Metabolism—MTHFR—urinary bladder cancer	1.01e-05	6.79e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.01e-05	6.76e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.01e-05	6.76e-05	CbGpPWpGaD
Testosterone—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	1e-05	6.76e-05	CbGpPWpGaD
Testosterone—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1e-05	6.75e-05	CbGpPWpGaD
Testosterone—ABCG2—Metabolism—NCOR1—urinary bladder cancer	1e-05	6.73e-05	CbGpPWpGaD
Testosterone—ABCG2—Metabolism—GSTM1—urinary bladder cancer	1e-05	6.73e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—HPGDS—urinary bladder cancer	1e-05	6.72e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—ENO2—urinary bladder cancer	1e-05	6.72e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1e-05	6.72e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.94e-06	6.68e-05	CbGpPWpGaD
Testosterone—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	9.92e-06	6.67e-05	CbGpPWpGaD
Testosterone—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	9.92e-06	6.67e-05	CbGpPWpGaD
Testosterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	9.77e-06	6.57e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	9.75e-06	6.56e-05	CbGpPWpGaD
Testosterone—CYP11A1—Metabolism—PTGS2—urinary bladder cancer	9.72e-06	6.54e-05	CbGpPWpGaD
Testosterone—CYP1B1—Metabolism—MTHFR—urinary bladder cancer	9.72e-06	6.54e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—GSTT1—urinary bladder cancer	9.7e-06	6.52e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—RRM2—urinary bladder cancer	9.69e-06	6.52e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.6e-06	6.46e-05	CbGpPWpGaD
Testosterone—ABCG2—Metabolism—GPX1—urinary bladder cancer	9.59e-06	6.45e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	9.58e-06	6.44e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—NQO1—urinary bladder cancer	9.57e-06	6.44e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.55e-06	6.42e-05	CbGpPWpGaD
Testosterone—CYP3A7—Metabolism—GPX1—urinary bladder cancer	9.5e-06	6.39e-05	CbGpPWpGaD
Testosterone—ALB—Hemostasis—RHOA—urinary bladder cancer	9.49e-06	6.38e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—RRM2—urinary bladder cancer	9.46e-06	6.36e-05	CbGpPWpGaD
Testosterone—ABCG2—Metabolism—ERCC2—urinary bladder cancer	9.41e-06	6.33e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—NQO1—urinary bladder cancer	9.36e-06	6.29e-05	CbGpPWpGaD
Testosterone—SLC22A1—Metabolism—TYMS—urinary bladder cancer	9.34e-06	6.28e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	9.34e-06	6.28e-05	CbGpPWpGaD
Testosterone—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	9.33e-06	6.27e-05	CbGpPWpGaD
Testosterone—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	9.23e-06	6.21e-05	CbGpPWpGaD
Testosterone—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	9.23e-06	6.21e-05	CbGpPWpGaD
Testosterone—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.08e-06	6.1e-05	CbGpPWpGaD
Testosterone—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	9.06e-06	6.09e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—ENO2—urinary bladder cancer	8.98e-06	6.03e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	8.98e-06	6.03e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.92e-06	6e-05	CbGpPWpGaD
Testosterone—SLC22A3—Metabolism—PTGS2—urinary bladder cancer	8.91e-06	5.99e-05	CbGpPWpGaD
Testosterone—ABCG2—Metabolism—MTHFR—urinary bladder cancer	8.85e-06	5.95e-05	CbGpPWpGaD
Testosterone—SLC22A1—Metabolism—GPX1—urinary bladder cancer	8.84e-06	5.95e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—NQO1—urinary bladder cancer	8.84e-06	5.94e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—RRM2—urinary bladder cancer	8.84e-06	5.94e-05	CbGpPWpGaD
Testosterone—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	8.77e-06	5.9e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—HPGDS—urinary bladder cancer	8.76e-06	5.89e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—ENO2—urinary bladder cancer	8.76e-06	5.89e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	8.71e-06	5.85e-05	CbGpPWpGaD
Testosterone—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	8.7e-06	5.85e-05	CbGpPWpGaD
Testosterone—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	8.68e-06	5.84e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.58e-06	5.77e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.57e-06	5.76e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—GSTT1—urinary bladder cancer	8.5e-06	5.71e-05	CbGpPWpGaD
Testosterone—CYP11A1—Metabolism—PTEN—urinary bladder cancer	8.48e-06	5.7e-05	CbGpPWpGaD
Testosterone—MAOA—Metabolism—PPARG—urinary bladder cancer	8.4e-06	5.64e-05	CbGpPWpGaD
Testosterone—CYP19A1—Metabolism—PPARG—urinary bladder cancer	8.19e-06	5.51e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	8.18e-06	5.5e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—ENO2—urinary bladder cancer	8.18e-06	5.5e-05	CbGpPWpGaD
Testosterone—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	8.16e-06	5.49e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.14e-06	5.47e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—NQO1—urinary bladder cancer	8.11e-06	5.45e-05	CbGpPWpGaD
Testosterone—CYP11A1—Metabolism—EP300—urinary bladder cancer	8.09e-06	5.44e-05	CbGpPWpGaD
Testosterone—MAOA—Metabolism—CREBBP—urinary bladder cancer	8.07e-06	5.42e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—NQO1—urinary bladder cancer	8.06e-06	5.42e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	7.99e-06	5.37e-05	CbGpPWpGaD
Testosterone—ALB—Hemostasis—IL2—urinary bladder cancer	7.96e-06	5.35e-05	CbGpPWpGaD
Testosterone—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.96e-06	5.35e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	7.94e-06	5.34e-05	CbGpPWpGaD
Testosterone—CYP1B1—Metabolism—PPARG—urinary bladder cancer	7.89e-06	5.3e-05	CbGpPWpGaD
Testosterone—CYP19A1—Metabolism—CREBBP—urinary bladder cancer	7.87e-06	5.29e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.86e-06	5.29e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.82e-06	5.26e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.82e-06	5.26e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	7.81e-06	5.25e-05	CbGpPWpGaD
Testosterone—SLC22A3—Metabolism—PTEN—urinary bladder cancer	7.77e-06	5.22e-05	CbGpPWpGaD
Testosterone—CYP1B1—Metabolism—CREBBP—urinary bladder cancer	7.58e-06	5.09e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.48e-06	5.03e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	7.47e-06	5.02e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—TYMS—urinary bladder cancer	7.42e-06	4.99e-05	CbGpPWpGaD
Testosterone—SLC22A3—Metabolism—EP300—urinary bladder cancer	7.41e-06	4.98e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	7.37e-06	4.96e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	7.34e-06	4.93e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	7.34e-06	4.93e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—TYMS—urinary bladder cancer	7.26e-06	4.88e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—NQO1—urinary bladder cancer	7.24e-06	4.86e-05	CbGpPWpGaD
Testosterone—ABCG2—Metabolism—PPARG—urinary bladder cancer	7.17e-06	4.82e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	7.17e-06	4.82e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	7.17e-06	4.82e-05	CbGpPWpGaD
Testosterone—ALB—Hemostasis—EP300—urinary bladder cancer	7.14e-06	4.8e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.13e-06	4.8e-05	CbGpPWpGaD
Testosterone—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	7.13e-06	4.79e-05	CbGpPWpGaD
Testosterone—CYP3A7—Metabolism—PPARG—urinary bladder cancer	7.11e-06	4.78e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—NQO1—urinary bladder cancer	7.06e-06	4.75e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—GPX1—urinary bladder cancer	7.03e-06	4.72e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.02e-06	4.72e-05	CbGpPWpGaD
Testosterone—AR—Gene Expression—MYC—urinary bladder cancer	6.98e-06	4.69e-05	CbGpPWpGaD
Testosterone—ALB—Hemostasis—SRC—urinary bladder cancer	6.95e-06	4.67e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	6.9e-06	4.64e-05	CbGpPWpGaD
Testosterone—ABCG2—Metabolism—CREBBP—urinary bladder cancer	6.89e-06	4.63e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—GPX1—urinary bladder cancer	6.87e-06	4.62e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.86e-06	4.61e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—TYMS—urinary bladder cancer	6.86e-06	4.61e-05	CbGpPWpGaD
Testosterone—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	6.83e-06	4.59e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.82e-06	4.58e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	6.78e-06	4.56e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	6.78e-06	4.56e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	6.76e-06	4.55e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	6.75e-06	4.54e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	6.74e-06	4.53e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—GSTP1—urinary bladder cancer	6.72e-06	4.52e-05	CbGpPWpGaD
Testosterone—SLC22A1—Metabolism—PPARG—urinary bladder cancer	6.62e-06	4.45e-05	CbGpPWpGaD
Testosterone—MAOA—Metabolism—PTGS2—urinary bladder cancer	6.6e-06	4.44e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—NQO1—urinary bladder cancer	6.6e-06	4.44e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.54e-06	4.4e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.5e-06	4.37e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—GPX1—urinary bladder cancer	6.49e-06	4.36e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	6.49e-06	4.36e-05	CbGpPWpGaD
Testosterone—CYP19A1—Metabolism—PTGS2—urinary bladder cancer	6.44e-06	4.33e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.4e-06	4.3e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	6.37e-06	4.28e-05	CbGpPWpGaD
Testosterone—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	6.36e-06	4.27e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	6.34e-06	4.26e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—TYMS—urinary bladder cancer	6.29e-06	4.23e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—TYMS—urinary bladder cancer	6.25e-06	4.2e-05	CbGpPWpGaD
Testosterone—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	6.22e-06	4.18e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	6.21e-06	4.18e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	6.21e-06	4.18e-05	CbGpPWpGaD
Testosterone—CYP1B1—Metabolism—PTGS2—urinary bladder cancer	6.2e-06	4.17e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—NCOR1—urinary bladder cancer	6.18e-06	4.15e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—GSTM1—urinary bladder cancer	6.18e-06	4.15e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.12e-06	4.12e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	6.03e-06	4.06e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	5.99e-06	4.03e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—GPX1—urinary bladder cancer	5.95e-06	4e-05	CbGpPWpGaD
Testosterone—SLCO1A2—Metabolism—EP300—urinary bladder cancer	5.93e-06	3.99e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—GPX1—urinary bladder cancer	5.92e-06	3.98e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—GSTP1—urinary bladder cancer	5.89e-06	3.96e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	5.84e-06	3.93e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.84e-06	3.93e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	5.83e-06	3.92e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—ERCC2—urinary bladder cancer	5.81e-06	3.9e-05	CbGpPWpGaD
Testosterone—MAOA—Metabolism—PTEN—urinary bladder cancer	5.76e-06	3.87e-05	CbGpPWpGaD
Testosterone—ALB—Hemostasis—KRAS—urinary bladder cancer	5.75e-06	3.87e-05	CbGpPWpGaD
Testosterone—ABCG2—Metabolism—PTGS2—urinary bladder cancer	5.64e-06	3.79e-05	CbGpPWpGaD
Testosterone—CYP19A1—Metabolism—PTEN—urinary bladder cancer	5.62e-06	3.78e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—TYMS—urinary bladder cancer	5.61e-06	3.77e-05	CbGpPWpGaD
Testosterone—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	5.59e-06	3.76e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.58e-06	3.75e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	5.55e-06	3.73e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	5.55e-06	3.73e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	5.5e-06	3.7e-05	CbGpPWpGaD
Testosterone—MAOA—Metabolism—EP300—urinary bladder cancer	5.49e-06	3.69e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	5.49e-06	3.69e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—TYMS—urinary bladder cancer	5.48e-06	3.68e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—MTHFR—urinary bladder cancer	5.46e-06	3.67e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—NCOR1—urinary bladder cancer	5.41e-06	3.64e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—GSTM1—urinary bladder cancer	5.41e-06	3.64e-05	CbGpPWpGaD
Testosterone—CYP1B1—Metabolism—PTEN—urinary bladder cancer	5.41e-06	3.64e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	5.4e-06	3.63e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	5.4e-06	3.63e-05	CbGpPWpGaD
Testosterone—CYP19A1—Metabolism—EP300—urinary bladder cancer	5.36e-06	3.6e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.32e-06	3.58e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—GPX1—urinary bladder cancer	5.31e-06	3.57e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—PPARG—urinary bladder cancer	5.26e-06	3.54e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	5.24e-06	3.52e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	5.21e-06	3.51e-05	CbGpPWpGaD
Testosterone—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	5.21e-06	3.5e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—GPX1—urinary bladder cancer	5.18e-06	3.48e-05	CbGpPWpGaD
Testosterone—CYP1B1—Metabolism—EP300—urinary bladder cancer	5.16e-06	3.47e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—PPARG—urinary bladder cancer	5.14e-06	3.46e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—TYMS—urinary bladder cancer	5.12e-06	3.44e-05	CbGpPWpGaD
Testosterone—ALB—Hemostasis—TP53—urinary bladder cancer	5.11e-06	3.44e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—ERCC2—urinary bladder cancer	5.09e-06	3.42e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	5.06e-06	3.4e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	5.06e-06	3.4e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	5.05e-06	3.4e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	4.94e-06	3.32e-05	CbGpPWpGaD
Testosterone—ABCG2—Metabolism—PTEN—urinary bladder cancer	4.92e-06	3.31e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	4.9e-06	3.29e-05	CbGpPWpGaD
Testosterone—ALB—Hemostasis—HRAS—urinary bladder cancer	4.89e-06	3.29e-05	CbGpPWpGaD
Testosterone—CYP3A7—Metabolism—PTEN—urinary bladder cancer	4.88e-06	3.28e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—PPARG—urinary bladder cancer	4.86e-06	3.27e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—GPX1—urinary bladder cancer	4.84e-06	3.26e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—MTHFR—urinary bladder cancer	4.78e-06	3.22e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	4.75e-06	3.2e-05	CbGpPWpGaD
Testosterone—ABCG2—Metabolism—EP300—urinary bladder cancer	4.69e-06	3.16e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	4.67e-06	3.14e-05	CbGpPWpGaD
Testosterone—CYP3A7—Metabolism—EP300—urinary bladder cancer	4.65e-06	3.13e-05	CbGpPWpGaD
Testosterone—SLC22A1—Metabolism—PTEN—urinary bladder cancer	4.54e-06	3.05e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	4.47e-06	3e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—PPARG—urinary bladder cancer	4.45e-06	2.99e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—PPARG—urinary bladder cancer	4.43e-06	2.98e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	4.35e-06	2.93e-05	CbGpPWpGaD
Testosterone—SLC22A1—Metabolism—EP300—urinary bladder cancer	4.33e-06	2.91e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	4.28e-06	2.88e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—CREBBP—urinary bladder cancer	4.25e-06	2.86e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	4.14e-06	2.78e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	4.04e-06	2.72e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—PPARG—urinary bladder cancer	3.97e-06	2.67e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—PPARG—urinary bladder cancer	3.88e-06	2.61e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	3.82e-06	2.57e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	3.82e-06	2.57e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—CREBBP—urinary bladder cancer	3.73e-06	2.51e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	3.63e-06	2.44e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—PPARG—urinary bladder cancer	3.62e-06	2.44e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—PTEN—urinary bladder cancer	3.61e-06	2.43e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—PTEN—urinary bladder cancer	3.53e-06	2.37e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	3.5e-06	2.35e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—PTGS2—urinary bladder cancer	3.48e-06	2.34e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	3.48e-06	2.34e-05	CbGpPWpGaD
Testosterone—CYP2B6—Metabolism—EP300—urinary bladder cancer	3.44e-06	2.31e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	3.37e-06	2.27e-05	CbGpPWpGaD
Testosterone—CYP3A5—Metabolism—EP300—urinary bladder cancer	3.36e-06	2.26e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	3.33e-06	2.24e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	3.33e-06	2.24e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—PTEN—urinary bladder cancer	3.33e-06	2.24e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	3.19e-06	2.15e-05	CbGpPWpGaD
Testosterone—CYP1A1—Metabolism—EP300—urinary bladder cancer	3.18e-06	2.14e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	3.14e-06	2.11e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	3.13e-06	2.1e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—PTEN—urinary bladder cancer	3.05e-06	2.05e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—PTGS2—urinary bladder cancer	3.05e-06	2.05e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—PTEN—urinary bladder cancer	3.04e-06	2.04e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.95e-06	1.98e-05	CbGpPWpGaD
Testosterone—CYP2C8—Metabolism—EP300—urinary bladder cancer	2.91e-06	1.96e-05	CbGpPWpGaD
Testosterone—ALB—Metabolism—EP300—urinary bladder cancer	2.9e-06	1.95e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.85e-06	1.92e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.73e-06	1.83e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—PTEN—urinary bladder cancer	2.66e-06	1.79e-05	CbGpPWpGaD
Testosterone—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.6e-06	1.75e-05	CbGpPWpGaD
Testosterone—ABCB1—Metabolism—EP300—urinary bladder cancer	2.54e-06	1.71e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—PTEN—urinary bladder cancer	2.49e-06	1.67e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.39e-06	1.61e-05	CbGpPWpGaD
Testosterone—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.37e-06	1.59e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.3e-06	1.54e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.88e-06	1.26e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.64e-06	1.1e-05	CbGpPWpGaD
Testosterone—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.56e-06	1.05e-05	CbGpPWpGaD
